SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Dorothea Lange Synthetic CCD

PatientDorothea Lange
Date of birth1964-05-26
IdentifiersMRN HR-ML045-SYN; SSN (made up) 000-45-9127
Document date2026-11-01
AuthorGwendolyn Ashford-Mensah, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for new fatigue, weakness, muscle pain, and falls 55 years after childhood polio; recent heartburn. Concerns: New tiredness and weakness, now in the good leg and the arms as well as the leg weakened by polio in childhood, with aching after work and two falls; Heartburn after meals and at night for three months; Wants to keep photographing in the field and fears having to give it up. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for muscle aching, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route2025-06-02activeS
Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth 30 to 60 minutes before breakfast, an eight-week trial for heartburnOne capsule once daily before breakfastOral route2026-02-09 to 2026-04-06completedS
Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (2000 units) by mouth once dailyTwo tablets once dailyOral route2026-02-25activeS
Calcium carbonate 500 mg chewable tablet, one or two tablets by mouth as needed for heartburn, no more than six tablets a day, while off omeprazole before the endoscopyOne or two tablets up to every 4 hours as neededOral route2026-04-20 to 2026-05-18completedS
Zoledronic acid 5 mg in 100 mL intravenous infusion over at least 15 minutes once a yearOne infusion once a yearIntravenous route2026-04-20activeS
Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth before breakfast for eight weeks to heal esophagitis, then the lowest dose that controls symptomsOne capsule once daily before breakfastOral route2026-05-18activeS

Procedures

ProcedureDatesStatusEvidence
Nerve conduction studies of both legs and the right arm: normal sensory and motor responses; no neuropathy or entrapment2026-02-18 to 2026-02-18completedS
Needle electromyography: large, long-duration, polyphasic motor units with reduced recruitment in the right quadriceps, tibialis anterior, and gastrocnemius; milder chronic reinnervation in the left vastus lateralis and right deltoid, muscles not known to have been affected; occasional fibrillation potentials in the right tibialis anterior; no myopathic units and no decrement on repetitive stimulation2026-02-18 to 2026-02-18completedS
Bone density scan (DXA) of the lumbar spine and both hips, with vertebral fracture assessment: osteoporosis of the right femoral neck; no vertebral fracture2026-02-25 to 2026-02-25completedS
Seated spirometry: forced vital capacity 2.52 L (92 percent of predicted), FEV1/FVC 78 percent; normal2026-02-25 to 2026-02-25completedS
Home overnight pulse oximetry: mean oxygen saturation 94 percent, oxygen desaturation index 3 per hour, no sustained desaturation; no nocturnal hypoventilation or sleep apnea pattern2026-03-10 to 2026-03-10completedS
Outpatient physical therapy, twelve weeks: individualized non-fatiguing strengthening and aerobic training with rest days, warm-water exercise, gait and balance training, and energy conservation2026-03-03 to 2026-05-26completedS
Custom lightweight carbon-fiber ankle-foot orthosis for the right leg, fitted and adjusted, with a single-point cane for the left hand2026-03-24 to 2026-03-24completedS
Intravenous infusion of zoledronic acid 5 mg over 30 minutes, after checking calcium, vitamin D, and creatinine; tolerated2026-04-20 to 2026-04-20completedS
Upper endoscopy with biopsies, three and a half weeks off omeprazole, under moderate sedation at reduced doses with continuous oxygen saturation and carbon dioxide monitoring: Los Angeles grade B esophagitis; 2 cm sliding hiatal hernia; regular squamocolumnar junction with no columnar-lined esophagus (no Barrett's esophagus); stomach with healed changes of the earlier ulcer operation and no ulcer; gastric biopsies without Helicobacter pylori2026-05-01 to 2026-05-01completedS

Immunizations

DateVaccineStatusEvidence
2025-10-20Influenza vaccine, 2025-2026 seasoncompletedS
2019-04-15Tdap vaccinecompletedS
2026-09-28Influenza vaccine, 2026-2027 seasoncompletedS
2026-09-28Pneumococcal conjugate vaccine PCV20completedS
2026-09-28Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1902Polio at age seven, leaving a weakened right leg and a lifelong limpD (CLM-0002)
1945 to 1948Severe stomach ulcers controlled by surgeryD (CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
New tiredness and weakness, now in the good leg and the arms as well as the leg weakened by polio in childhood, with aching after work and two fallsactiveS
Heartburn after meals and at night for three monthsactiveS
Wants to keep photographing in the field and fears having to give it upactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 13.1 on 2026-02-09; Leukocytes [#/volume] in Blood by Automated count 8.6 on 2026-04-22; Platelets [#/volume] in Blood by Automated count 248 on 2026-02-09; Sodium [Moles/volume] in Serum or Plasma 140 on 2026-02-09; Potassium [Moles/volume] in Serum or Plasma 4.3 on 2026-02-09; Creatinine [Mass/volume] in Serum or Plasma 0.8 on 2026-04-22; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 93 on 2026-04-20; Glucose [Mass/volume] in Serum or Plasma 92 on 2026-02-09; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 2026-02-09; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 2026-02-09; Creatine kinase [Enzymatic activity/volume] in Serum or Plasma 228 on 2026-02-09; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 512 on 2026-02-09; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 2026-04-20; Calcium [Mass/volume] in Serum or Plasma 8.9 on 2026-04-22; Albumin [Mass/volume] in Serum or Plasma 4.2 on 2026-02-09; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 17 on 2026-02-09; Erythrocyte [Sedimentation Rate] in Blood by Westergren method 12 on 2026-02-09; C reactive protein [Mass/volume] in Serum or Plasma 0.3 on 2026-02-09; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 2026-08-17; Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 on 2026-08-17; Parathyrin.intact [Mass/volume] in Serum or Plasma 58 on 2026-02-25; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 82 on 2026-02-25; Phosphate [Mass/volume] in Serum or Plasma 3.4 on 2026-02-25; Magnesium [Mass/volume] in Serum or Plasma 2 on 2026-02-25; Forced vital capacity [Volume] Respiratory system 2.52 on 2026-02-25; FVC measured/predicted 92 on 2026-02-25; FEV1/FVC 78 on 2026-02-25; DXA Lumbar spine [T-score] Bone density -1.8 on 2026-02-25; DXA Femur - right [T-score] Bone density -2.7 on 2026-02-25; DXA Femur - left [T-score] Bone density -1.6 on 2026-02-25; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-09-28; Total score [AUDIT-C] 2 on 2026-09-28 [S]

Strengths and supports: Strengths: decades of adapting her work to a weak leg without letting it show; a precise observer who keeps notes; supports: her husband and a photographer colleague who assists in the field [S]

Problems

ProblemClinical statusVerificationCodeProvenance
New fatigue and slowly increasing weakness for about 18 months, in the left leg and both arms as well as the right leg weakened by polio at seven, with aching muscle pain after work and cold intolerance of the right leg; cause to be establishedresolvedconfirmed M62.81S — Synthetic presenting concern at the index visit, superseded by the diagnosis of post-polio syndrome at the second visit; the paralytic polio of 1902 is documented (D).
Post-polio syndrome (modified March of Dimes criteria met): new weakness of the left quadriceps and both shoulder girdles and increased weakness of the right leg, with fatigue, muscle pain, and cold intolerance, more than 50 years after paralytic polio with partial recovery and decades of stable function; nerve conduction normal; EMG chronic reinnervation in both legs and the right deltoid; other causes excludedactiveconfirmed G14S — Synthetic modern diagnosis; the childhood polio is documented (D), and her biographer's account of post-polio symptoms later in life is a retrospective interpretation (R). No neurological finding from her lifetime is used.
Heartburn and regurgitation after meals and at night for three months, three to four times a week; no difficulty swallowing, weight loss, vomiting, bleeding, or anemiaresolvedconfirmed R12S — Synthetic presenting symptom at the index visit, superseded by the endoscopic diagnosis at the fourth visit.
Gastroesophageal reflux disease with Los Angeles grade B erosive esophagitis on upper endoscopy off proton pump inhibitor; no Barrett's esophagusactiveconfirmed K21.00S — Synthetic endoscopic diagnosis; it does not echo or foreshadow her later documented illness.
Small (2 cm) sliding hiatal hernia on upper endoscopyactiveconfirmed K44.9S — Synthetic endoscopic finding.
Osteoporosis, worst at the right hip on the polio-weakened side (right femoral neck T-score -2.7; left -1.6; lumbar spine -1.8), with vitamin D insufficiency; no vertebral fracture on assessment; 10-year FRAX risk about 16 percent major osteoporotic and 4.5 percent hipactiveconfirmed M81.8S — Synthetic bone density result; disuse of a polio-affected limb lowers bone density on that side.
Two falls in the past year without injury, from catching the right footactiveconfirmed Z91.81S — Synthetic fall history at presentation.
Surgery for severe stomach ulcers in her early fifties; no ulcer symptoms since; avoids nonsteroidal anti-inflammatory drugsactiveconfirmed Z87.11S — Synthetic modern history entry linked to the documented ulcers and surgery of the late 1940s (D); the type of operation is not known.
Acute-phase reaction two days after the first zoledronic acid infusion: fever to 38.1 °C, muscle and joint aching, and headache, without signs of infection; calcium normal; resolved in three days with acetaminophen and fluidsresolvedconfirmed T50.995AS — Synthetic expected adverse effect of a first intravenous bisphosphonate dose.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-09Hemoglobin [Mass/volume] in Blood13.1g/dL12-15.5 g/dLNormalS
2026-02-09Leukocytes [#/volume] in Blood by Automated count6.110*3/uL4-11 10*3/uLNormalS
2026-02-09Platelets [#/volume] in Blood by Automated count24810*3/uL150-400 10*3/uLNormalS
2026-02-09Sodium [Moles/volume] in Serum or Plasma140mmol/L136-145 mmol/LNormalS
2026-02-09Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2026-02-09Creatinine [Mass/volume] in Serum or Plasma0.7mg/dL0.5-1.1 mg/dLNormalS
2026-02-09Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M93mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-02-09Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-02-09Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
2026-02-09Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.4-4 mIU/LNormalS
2026-02-09Creatine kinase [Enzymatic activity/volume] in Serum or Plasma228U/L26-192 U/LHighS
2026-02-09Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma512pg/mL232-1245 pg/mLNormalS
2026-02-0925-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma22ng/mL30-100 ng/mLLowS
2026-02-09Calcium [Mass/volume] in Serum or Plasma9.3mg/dL8.6-10.3 mg/dLNormalS
2026-02-09Albumin [Mass/volume] in Serum or Plasma4.2g/dL3.5-5 g/dLNormalS
2026-02-09Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma17U/L<=33 U/LNormalS
2026-02-09Erythrocyte [Sedimentation Rate] in Blood by Westergren method12mm/h<=30 mm/hNormalS
2026-02-09C reactive protein [Mass/volume] in Serum or Plasma0.3mg/dL<=0.5 mg/dLNormalS
2026-02-09Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-02-09Pain severity - 0-10 verbal numeric rating [Score] - Reported6{score}S
2026-02-25Parathyrin.intact [Mass/volume] in Serum or Plasma58pg/mL15-65 pg/mLNormalS
2026-02-25Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma82U/L44-147 U/LNormalS
2026-02-25Phosphate [Mass/volume] in Serum or Plasma3.4mg/dL2.5-4.5 mg/dLNormalS
2026-02-25Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.7-2.4 mg/dLNormalS
2026-02-25Forced vital capacity [Volume] Respiratory system2.52L>=2.2 LNormalS
2026-02-25FVC measured/predicted92%80% of predicted or more is normalNormalS
2026-02-25FEV1/FVC78%>=70%NormalS
2026-02-25DXA Lumbar spine [T-score] Bone density-1.8{T-score}-2.5 or lower is osteoporosisLowS
2026-02-25DXA Femur - right [T-score] Bone density-2.7{T-score}-2.5 or lower is osteoporosisLowS
2026-02-25DXA Femur - left [T-score] Bone density-1.6{T-score}-2.5 or lower is osteoporosisLowS
2026-04-2025-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma34ng/mL30-100 ng/mLNormalS
2026-04-20Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-04-20Creatinine [Mass/volume] in Serum or Plasma0.7mg/dL0.5-1.1 mg/dLNormalS
2026-04-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M93mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-04-20Pain severity - 0-10 verbal numeric rating [Score] - Reported5{score}S
2026-05-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-05-18Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S
2026-08-17Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
2026-08-17Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
2026-04-22Calcium [Mass/volume] in Serum or Plasma8.9mg/dL8.6-10.3 mg/dLNormalS
2026-04-22Leukocytes [#/volume] in Blood by Automated count8.610*3/uL4-11 10*3/uLNormalS
2026-04-22Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.5-1.1 mg/dLNormalS
2026-09-28Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-09-28Total score [AUDIT-C]2{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-02-09Body height152cmS
2026-02-09Body weight50.5kgS
2026-02-09Body mass index (BMI) [Ratio]21.9kg/m2S
2026-02-09Systolic blood pressure128mm[Hg]S
2026-02-09Diastolic blood pressure78mm[Hg]S
2026-02-09Heart rate76/minS
2026-02-09Respiratory rate14/minS
2026-02-09Body temperature36.6CelS
2026-02-09Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-02-25Body height152cmS
2026-02-25Body weight50.3kgS
2026-02-25Body mass index (BMI) [Ratio]21.8kg/m2S
2026-02-25Systolic blood pressure126mm[Hg]S
2026-02-25Diastolic blood pressure76mm[Hg]S
2026-02-25Heart rate74/minS
2026-02-25Respiratory rate14/minS
2026-02-25Body temperature36.5CelS
2026-02-25Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-04-20Body height152cmS
2026-04-20Body weight50.6kgS
2026-04-20Body mass index (BMI) [Ratio]21.9kg/m2S
2026-04-20Systolic blood pressure124mm[Hg]S
2026-04-20Diastolic blood pressure76mm[Hg]S
2026-04-20Heart rate72/minS
2026-04-20Respiratory rate14/minS
2026-04-20Body temperature36.6CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-05-18Body height152cmS
2026-05-18Body weight50.8kgS
2026-05-18Body mass index (BMI) [Ratio]22kg/m2S
2026-05-18Systolic blood pressure122mm[Hg]S
2026-05-18Diastolic blood pressure74mm[Hg]S
2026-05-18Heart rate70/minS
2026-05-18Respiratory rate14/minS
2026-05-18Body temperature36.6CelS
2026-05-18Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-17Body height152cmS
2026-08-17Body weight51kgS
2026-08-17Body mass index (BMI) [Ratio]22.1kg/m2S
2026-08-17Systolic blood pressure124mm[Hg]S
2026-08-17Diastolic blood pressure76mm[Hg]S
2026-08-17Heart rate72/minS
2026-08-17Respiratory rate14/minS
2026-08-17Body temperature36.7CelS
2026-08-17Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-04-22Body height152cmS
2026-04-22Body weight50.2kgS
2026-04-22Body mass index (BMI) [Ratio]21.7kg/m2S
2026-04-22Systolic blood pressure118mm[Hg]S
2026-04-22Diastolic blood pressure72mm[Hg]S
2026-04-22Heart rate92/minS
2026-04-22Respiratory rate16/minS
2026-04-22Body temperature38.1CelS
2026-04-22Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-09-28Body height152cmS
2026-09-28Body weight51.2kgS
2026-09-28Body mass index (BMI) [Ratio]22.2kg/m2S
2026-09-28Systolic blood pressure122mm[Hg]S
2026-09-28Diastolic blood pressure74mm[Hg]S
2026-09-28Heart rate70/minS
2026-09-28Respiratory rate14/minS
2026-09-28Body temperature36.6CelS
2026-09-28Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-02-09Primary care visit for new fatigue, weakness, muscle pain, and falls 55 years after childhood polio; recent heartburnfinishedS
2026-02-25Diagnosis of post-polio syndrome with the neuromuscular rehabilitation consultation the same day; bone density and spirometryfinishedS
2026-04-20Review after eight weeks of pacing and physical therapy; first zoledronic acid infusion; planning endoscopy after heartburn returned off omeprazolefinishedS
2026-05-18Endoscopy results and reflux treatment; post-polio syndrome follow-upfinishedS
2026-08-17Six-month review of post-polio syndrome, falls, bone health, and reflux step-downfinishedS
2026-04-22Same-day sick visit for fever and aching after zoledronic acidfinishedS
2026-09-28Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Work-up of new weakness as a diagnosis of exclusion: blood count, chemistry, glucose and HbA1c, TSH, B12, vitamin D, calcium, creatine kinase, ESR and CRP today; nerve conduction studies and needle EMG; PHQ-9; sleep screencompletedGL-MOD-PPS-2001, GL-EFNS-PPS-2006S
Neuromuscular physical medicine and rehabilitation consultation, to confirm or exclude post-polio syndrome and plan exercise, orthoses, and work adaptationscompletedGL-EFNS-PPS-2006S
Heartburn: lifestyle measures and an eight-week trial of omeprazole 20 mg before breakfast; endoscopy if alarm features appear or if symptoms return when it is stoppedcompletedGL-ACG-GERD-2022S
Fall prevention: home hazard review, footwear, night lighting, rails on the garden path, and a bone density scan for a woman with a weakened limb and fallscompletedGL-FALLS-2022, GL-CMID-2026S
Pain care: acetaminophen as needed, heat, pacing, and stretching; no nonsteroidal anti-inflammatory drugs after her ulcer surgerycompletedGL-EFNS-PPS-2006S
Energy conservation and pacing: plan field days with rest breaks, a lighter camera and a harness instead of a shoulder bag, a seat stick, an assistant to carry the tripod, and a rest day after each field day; stop activity before fatiguecompletedGL-EFNS-PPS-2006S
Supervised non-fatiguing exercise for twelve weeks (strengthening at submaximal effort with rest days, aerobic training, warm-water exercise, gait and balance training), then a home programcompletedGL-EFNS-PPS-2006S
Custom lightweight carbon-fiber ankle-foot orthosis for right foot drop and knee instability, and a cane in the left hand; reassess for a knee-ankle-foot orthosis if knee buckling continuescompletedGL-EFNS-PPS-2006S
Respiratory and sleep assessment: baseline spirometry and home overnight oximetry, with yearly spirometry and earlier review for breathlessness, morning headache, or swallowing troublecompletedGL-EFNS-PPS-2006S
Osteoporosis: vitamin D3 2000 units daily and dietary calcium; zoledronic acid 5 mg yearly once vitamin D is replete, given intravenously because of active reflux symptoms; DXA in two years; secondary-causes tests including a 24-hour urine calciumcompletedGL-CMID-2026, GL-AACE-OP-2020, GL-FDA-ZOL-2026S
Sedation and anesthesia precautions for post-polio syndrome recorded in the chart: reduced sedative and opioid doses, continuous oxygen and carbon dioxide monitoring, keep warm, careful positioning of the weak leg, and caution with neuromuscular blocking drugscompletedGL-ANES-PPS-2025, GL-ANES-PPS-2005S
Upper endoscopy after two to four weeks off omeprazole, because heartburn returned within days of stopping it, with an antacid as needed meanwhile; sedation precautions for post-polio syndromecompletedGL-ACG-GERD-2022, GL-ANES-PPS-2025S
Grade B reflux esophagitis: omeprazole 20 mg daily for eight weeks, then step down to the lowest dose that controls symptoms; weight-neutral lifestyle measures, no meals within three hours of bed, head of the bed raised; no Barrett's surveillance after a negative examinationcompletedGL-ACG-GERD-2022, GL-ACG-BE-2022S

Goals

GoalTargetStatusOutcomeProvenance
Find the cause of the new weakness and fatigue within four weeks, with other treatable causes excluded2026-02-25completedPost-polio syndrome diagnosed at 16 days after the tests excluded thyroid disease, anemia, diabetes, B12 deficiency, neuropathy, and myopathyS
No falls over the next six months2026-08-17completedNo falls since the orthosis and cane; Timed Up and Go 11.2 secondsS
Keep working in the field at least two days a week, with planned rests, without exhaustion the next day2026-12-31activeWorking two field days a week with a lighter camera, a seat stick, and rest breaksS
Establish the cause of the heartburn and control it on the lowest effective therapy2026-05-18completedEndoscopy showed grade B esophagitis without Barrett's esophagus; omeprazole restarted, symptoms controlledS
Replete vitamin D and start fracture-protective treatment2026-04-20completedVitamin D 34 ng/mL; first zoledronic acid infusion givenS

Functional Status

Mental Status